These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38889396)

  • 1. Quinolone bioisosteres of phenolic GluN2B-selective NMDA receptor antagonists.
    Rathing F; Schepmann D; Wünsch B
    Arch Pharm (Weinheim); 2024 Jun; ():e2400279. PubMed ID: 38889396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenol-Benzoxazolone bioisosteres: Synthesis and biological evaluation of tricyclic GluN2B-selective N-methyl- d-aspartate receptor antagonists.
    Markus A; Schreiber JA; Goerges G; Frehland B; Seebohm G; Schepmann D; Wünsch B
    Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200147. PubMed ID: 35606894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiophene bioisosteres of GluN2B selective NMDA receptor antagonists: Synthesis and pharmacological evaluation of [7]annuleno[b]thiophen-6-amines.
    Baumeister S; Schepmann D; Wünsch B
    Bioorg Med Chem; 2020 Jan; 28(2):115245. PubMed ID: 31843460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxymethyl bioisosteres of phenolic GluN2B-selective NMDA receptor antagonists: Design, synthesis and pharmacological evaluation.
    Temme L; Frehland B; Schepmann D; Robaa D; Sippl W; Wünsch B
    Eur J Med Chem; 2018 Jan; 144():672-681. PubMed ID: 29289890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative allosteric modulators of NMDA receptors with GluN2B subunit: Alanine-derived benzoxazolone bioisosteres of 2-methyl-3-benzazepine-1,7-diols.
    Markus A; Frehland B; Schepmann D; Wünsch B
    Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200177. PubMed ID: 35606890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Methyltetrahydro-3-benzazepin-1-ols - The missing link in SAR of GluN2B selective NMDA receptor antagonists.
    Dey S; Schepmann D; Wünsch B
    Bioorg Med Chem; 2018 Jan; 26(2):501-508. PubMed ID: 29254894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the phenolic OH moiety of GluN2B-selective NMDA antagonists with 3-benzazepine scaffold.
    Dey S; Schepmann D; Wünsch B
    Bioorg Med Chem Lett; 2016 Feb; 26(3):889-893. PubMed ID: 26750254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzimidazolone bioisosteres of potent GluN2B selective NMDA receptor antagonists.
    Lütnant I; Schepmann D; Wünsch B
    Eur J Med Chem; 2016 Jun; 116():136-146. PubMed ID: 27061977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deconstruction - Reconstruction: Analysis of the Crucial Structural Elements of GluN2B-Selective, Negative Allosteric NMDA Receptor Modulators with 3-Benzazepine Scaffold.
    Ritter N; Korff M; Markus A; Schepmann D; Seebohm G; Schreiber JA; Wünsch B
    Cell Physiol Biochem; 2021 Mar; 55(S3):1-13. PubMed ID: 33656308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists derived from 3-benzazepines: synthesis and pharmacological evaluation of benzo[7]annulen-7-amines.
    Benner A; Bonifazi A; Shirataki C; Temme L; Schepmann D; Quaglia W; Shoji O; Watanabe Y; Daniliuc C; Wünsch B
    ChemMedChem; 2014 Apr; 9(4):741-51. PubMed ID: 24677663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the 4-phenylbutyl side chain of potent 3-benzazepine-based GluN2B receptor antagonists.
    Wagner M; Schepmann D; Ametamey SM; Wünsch B
    Bioorg Med Chem; 2019 Aug; 27(16):3559-3567. PubMed ID: 31255496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deconstruction - reconstruction approach to analyze the essential structural elements of tetrahydro-3-benzazepine-based antagonists of GluN2B subunit containing NMDA receptors.
    Dey S; Temme L; Schreiber JA; Schepmann D; Frehland B; Lehmkuhl K; Strutz-Seebohm N; Seebohm G; Wünsch B
    Eur J Med Chem; 2017 Sep; 138():552-564. PubMed ID: 28704758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative allosteric modulators of NMDA receptors with GluN2B subunit: synthesis of β-aminoalcohols by epoxide opening and subsequent rearrangement.
    Korff M; Lüken J; Schmidt J; Schepmann D; Goerges G; Ritter N; Disse P; Schreiber JA; Seebohm G; Wünsch B
    Org Biomol Chem; 2023 Sep; 21(37):7616-7638. PubMed ID: 37682049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridine bioisosteres of potent GluN2B subunit containing NMDA receptor antagonists with benzo[7]annulene scaffold.
    Zscherp R; Baumeister S; Schepmann D; Wünsch B
    Eur J Med Chem; 2018 Sep; 157():397-404. PubMed ID: 30103189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, GluN2B affinity and selectivity of benzo[7]annulen-7-amines.
    Gawaskar S; Schepmann D; Bonifazi A; Wünsch B
    Bioorg Med Chem; 2014 Dec; 22(23):6638-6646. PubMed ID: 25458498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indazole as a Phenol Bioisostere: Structure-Affinity Relationships of GluN2B-Selective NMDA Receptor Antagonists.
    Lüken J; Goerges G; Ritter N; Disse P; Schreiber JA; Schmidt J; Frehland B; Schepmann D; Seebohm G; Wünsch B
    J Med Chem; 2023 Aug; 66(16):11573-11588. PubMed ID: 37580890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σ
    Thum S; Schepmann D; Ayet E; Pujol M; Nieto FR; Ametamey SM; Wünsch B
    Eur J Med Chem; 2019 Sep; 177():47-62. PubMed ID: 31129453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and receptor binding of thiophene bioisosteres of potent GluN2B ligands with a benzo[7]annulene-scaffold.
    Baumeister S; Schepmann D; Wünsch B
    Medchemcomm; 2019 Feb; 10(2):315-325. PubMed ID: 30881618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacement of benzylic hydroxy group by vinyl or hydroxymethyl moiety at the 3-benzazepine scaffold retaining GluN2B affinity.
    Rath S; Schepmann D; Wünsch B
    Bioorg Med Chem; 2017 Oct; 25(20):5365-5372. PubMed ID: 28797770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of oxazolo-annulated 3-benzazepines designed by merging two negative allosteric NMDA receptor modulators.
    Markus A; Schepmann D; Wünsch B
    Arch Pharm (Weinheim); 2022 Jun; 355(6):e2200020. PubMed ID: 35224754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.